Trial Details
Trial status:
In set-up (funded)
Recruitment start date:
Chief Investigator:
Professor Allan Hackshaw
Recruitment target:
EudraCT number:
Contact details:
Lay summary:
Lung Trans
Biomarker Analysis to Predict Response in Lung Cancer
Design: Lung Trans is a non-interventional laboratory study. 
Treatment: N/A
Key inclusion/exclusion criteria: N/A
Duration of recruitment: N/A

The Lung Trans study aims to develop a greater understanding of lung cancer outcomes by performing molecular and non-molecular profiling of samples to examine biomarkers in patients with lung cancer.  The study will initially utilise biological samples from three lung cancer studies (TACTIC, TOPICAL, and ET) which are now closed; samples from other approved studies will be added over time.  We will investigate how these biomarkers are associated with clinical outcomes such as progression and death (prognostic factors), and whether they could be used as predictive markers to predict how well patients respond to different treatments. 

Trial protocols
Trial protocols must not be applied to patients treated outside trials. UCL CTC can only ensure that approved trial investigators are provided with amendments to protocols.
No protocols have been currently made available for download
Trial documents
No documents have been currently made available for download
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road

View map
+44 (0)20 7679 9898 (General CTC Enquiries)
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2024 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us